![David Neafus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Neafus
Vorstandsvorsitzender bei Ninox Petroleum Ltd.
Aktive Positionen von David Neafus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Avaxia Biologics, Inc.
![]() Avaxia Biologics, Inc. BiotechnologyHealth Technology Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA. | Finanzdirektor/CFO | - | - |
Ninox Petroleum Ltd. | Vorstandsvorsitzender | - | - |
Karriereverlauf von David Neafus
Ehemalige bekannte Positionen von David Neafus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Link Medicine Corp.
![]() Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Gründer | 01.01.2005 | - |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Comptroller/Controller/Auditor | - | - |
INFINITY PHARMACEUTICALS, INC. | Verwaltungsdirektor | - | - |
Finanzdirektor/CFO | - | - | |
ALNYLAM PHARMACEUTICALS, INC. | Finanzdirektor/CFO | - | - |
GlycoFi, Inc.
![]() GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Finanzdirektor/CFO | - | - |
KPMG LLP
![]() KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | - | - |
Ausbildung von David Neafus
University of Minnesota | Undergraduate Degree |
Bentley University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 10 |
Australien | 2 |
Operativ
Director of Finance/CFO | 4 |
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
KPMG LLP
![]() KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
GlycoFi, Inc.
![]() GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
Avaxia Biologics, Inc.
![]() Avaxia Biologics, Inc. BiotechnologyHealth Technology Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Ninox Petroleum Ltd. | |
Link Medicine Corp.
![]() Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- David Neafus
- Erfahrung